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TO THE EDITOR
Dyer et al. (2012) examined risk factors
for basal cell carcinoma (BCC) in a
relatively small cohort of veterans, who
participated in the USA Veterans Affairs
Topical Tretinoin Chemoprevention
Trial. In addition to the usual, well-
known predictors; that is, age, sun
sensitivity, a history of prior BCCs, and
occupational UV exposure, they found
an association with a self-reported
history of eczema (atopic dermatitis,
AD). In their accompanying editorial,
Gamba and Tang (2012) examine
competing hypotheses to explain this
new association. Because none of the
Veterans Affairs (VA) subjects had been
treated with calcineurin inhibitors or
other immunosuppressives, they then
speculate that either the chronic
inflammation in AD or other forms of
anti-inflammatory therapy for AD, such
as topical glucocorticoids or UV
phototherapy, could have favored the
development of BCCs.
Yet, the BCCs in the VA patients did
not occur in previously eczematous
sites, suggesting to us that some inherent
difference in the structure of the epider-
mis in subjects at risk for AD could
explain the association of AD with an
increased prevalence of BCCs. We pro-
pose two alternate epidermis-based
explanations, either or both of which
could be operative. First, assuming that
a substantial subgroup of these VA
patients have Northern European ances-
try, then as many as 40–50% of the
subjects with a prior history of AD could
bear loss-of-function FLG mutations
(Irvine et al., 2011). Proteolytic
degradation of FLG, followed by either
enzymatic or non-enzymatic deimina-
tion of its constituent amino acids,
yields a mixture of polycarboxylic
acids that includes trans-urocanic acid
(t-UCA) (Scott et al., 1982), an important
endogenous UV-B filter (Finlay-Jones
and Hart, 1998). Reduction in the
t-UCA content of stratum corneum (SC)
might lead to greater UV-B penetration
into the nucleated cell layers with an
increased risk of malignant transfor-
mation. On the other hand, t-UCA is
photo-isomerized by UV-B to cis-UCA
(c-UCA), a potent, local immunosuppres-
sive molecule (Kripke, 1984; de Fine
Olivarius et al., 1998). Thus, the possibi-
lity that t-UCA deficiency, resulting from
reduced FLG, could increase BCCs in
this population through greater UV-B
penetration must be weighed against
the potential benefits of reduced c-UCA
generation from t-UCA in a FLG-
deficient, tumor environment.
A second, less ambiguous epidermis-
based explanation could be the thinner
SC that occurs in AD (Cork et al., 2009;
Voegeli et al., 2009). The thinner SC in
AD could result from inherited, gain-
of-function mutations in kallikrein7
(KLK7; Vasilopoulos et al., 2011); loss-
of-function mutations in SPINK5, which
encode the KLK inhibitor, LEKTI
(Sprecher et al., 2001); and/or a FLG
allele-dependent increase in the pH of
the SC that accompanies the barrier
abnormality, even in non-inflamed,
filaggrin-deficient epidermis (Gruber
et al., 2011). An increase in pH
inevitably would lead to activation of
KLKs (Cork et al., 2009; Voegeli et al.,
2009). These alterations likely converge
alone or additively to increase KLK
activity and SC thinning in both
lesional and non-lesional skin of AD
(Elias and Schmuth, 2009). Because at
least 50% of UV-B in lightly pigmented
individuals is interdicted at the level
of the SC (Thomson, 1955), a thinner-
than-normal SC then would inevitably
predispose to the development of BCCs
by allowing penetration of a larger
proportion of incident UV-B.
The final message should be, how-
ever, that AD is now generally acknowl-
edged to display a prominent epidermal
component, with several of its immuno-
logical sequelae occurring downstream
of a flawed barrier (Elias et al., 2008).
Hypotheses of causation and association
with other epidermal diseases, such as
BCC, should not overlook the potential
role of epidermal pathology in disease
pathogenesis.
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TO THE EDITOR
In generalized vitiligo (GV), patches of
depigmented skin and overlying hair
(Picardo and Taı¨eb, 2010) result from
autoimmune destruction of melanocytes
by skin-homing autoreactive cytotoxic T
lymphocytes (CTLs) (Ogg et al., 1998).
In two genome-wide association studies
(GWAS) to identify GV susceptibility
loci in European-derived white (EUR)
patients (GWAS1, GWAS2; Jin et al.,
2010, 2012), we detected association
with GZMB, encoding granzyme B, a
serine protease marker of activated CTLs
(Sattar et al., 2003). In concert with
perforin, GZMB mediates direct and
caspase-mediated apoptosis of target
cells (Granville, 2010; Ewen et al.,
2012), as well as proteolytic cleavage
of autoantigens, creating or exposing
autoimmune epitopes that may initiate
or propagate the autoimmune process
(Darrah and Rosen, 2010).
Meta-analysis of GWAS1, GWAS2,
and replication study data for single-
nucleotide polymorphisms (SNPs) geno-
typed in the GZMB region (Jin et al.,
2012) showed greatest association with
rs8192917-C (P¼5.60 109, odds
ratio 1.22), a common nonsynonymous
SNP (R55Q) that is in very strong linkage
disequilibrium with two other common
nonsynonymous SNPs, rs11539752
(P94A; r2¼0.99) and rs2236338
(Y247H; r2¼ 0.93). Together, these
three variants define two predominant
haplotypic multivariant GZMB polypep-
tide isoforms 55Q-94P-247Y (termed
‘‘QPY’’) versus 55R-94A-247H (‘‘RAH’’)
(McIlroy et al., 2003; Zaitsu et al.,
2004). To carry out higher-resolution
analysis of association of GV with
SNPs in the GZMB region, we first
imputed genotypes for all SNPs in the
1,000 Genomes Project phase 1 integra-
ted variant call set (21 June 2012
release) across the 160-kb region
(chr14:25045130–25204958) showing
even nominal association with GV in
the combined GWAS1 and GWAS2
dataset (Jin et al., 2010, 2012), from
101.5 kb upstream of GZMB through
55 kb downstream. After quality control
procedures, there were 464 genotyped
or imputed SNPs in 7,202 total subjects
(Supplementary Table S1 online). In this
analysis, the most significant SNP was
rs10909625 (P¼1.03 108), a synon-
ymous variant at codon K80 (Table 1).
To determine which SNPs in the GZMB
region might be causal for GV suscept-
ibility, we then carried out logistic
regression, individually testing each of
463 SNPs conditional on rs10909625.
This analysis indicated that there is only
one primary association signal in the
GZMB region, represented by nine SNPs
(Table 1) whose effects cannot be dis-
tinguished (Supplementary Table S2
online) owing to very strong linkage
disequilibrium (Supplementary Figure
S1 online). These include rs8192917
(R55Q) and rs11539752 (P94Q); none
of the other seven primary asso-
ciated SNPs (rs6573910, rs6573911,
rs45628336, rs113822535, rs45442494,
rs1126639, and rs10909625) are pre-
dicted to have functional consequences.
In contrast, the associations of
rs2236338 (Y247H), as well as that of
another potentially functional SNP
rs2273844 (stop codon within the 50
untranslated region), were found to be
secondary.
Analysis of the haplotypes defined
by the three nonsynonymous SNPs
rs8192917-rs11539752-rs2236338 simi-
larly indicated that principal association
with GV is with the haplotype compris-
ing rs8192917-C—rs11539752-C. As
shown in Table 2, this constitutes the
higher-risk haplotype (odds ratio 1.27;
P¼4.42108), compared with the
haplotype that also includes the high-
risk G allele of rs2236338 (odds ratio
1.26; P¼3.26107). Nevertheless, it
is difficult to completely exclude anyAccepted article preview online 15 January 2013
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